This post is part of a developing series exploring borderline personality disorder through the lens of endogenous opioid regulation, neurodevelopment, and trauma.

Many autistic people, particularly those from groups that are historically underrecognized or mischaracterized in autism research, including women and gender-diverse people, are told later in life that their traits resemble borderline personality disorder (BPD). When autism is recognized, an earlier BPD diagnosis is often dismissed as a misdiagnosis, rather than understood as potentially co-occurring. Sometimes the overlap is explained as “autism plus trauma.” Neither framing fully captures what’s happening.

This post explores a different possibility: that chronic stress and misattunement during autistic development can alter the brain’s attachment- and pain-regulation systems in lasting biological ways, specifically the endogenous opioid system.

From this perspective, overlapping autism and BPD traits are not a contradiction. They are the predictable result of a neurodevelopmental difference growing up in an environment that was not built to meet it.

In recent years, BPD has increasingly been linked to dysregulation of the endogenous opioid system, particularly the κ-opioid receptor (KOR), encoded by the OPRK1 gene.¹ Molecular studies have found that individuals with BPD show altered DNA methylation patterns in OPRK1, with lower methylation correlating with greater symptom severity and reported childhood neglect. Separate postmortem research in people exposed to childhood abuse has identified hypomethylation in regulatory regions of OPRK1 in brain tissue, alongside reduced receptor expression, suggesting stress-mediated epigenetic adaptation of the opioid system.²

The endogenous opioid system regulates attachment, social bonding, stress buffering, pain perception, and affective stability. It therefore sits at the intersection of trauma and social experience.

Autistic children grow up in environments structured around allistic norms. Even in well-intentioned families, this often means chronic misattunement, sensory overload, social confusion, or emotional invalidation. These experiences may not always be labeled “trauma,” but they can represent sustained stress exposure during sensitive developmental periods. If early life stress is capable of reshaping opioid-system regulation via epigenetic mechanisms, then autistic individuals exposed to chronic misattunement may be biologically more vulnerable to later dysregulation of affect and attachment.

Seen this way, BPD in some autistic people, particularly those who must mask extensively to survive socially, is not simply misdiagnosis, nor purely personality pathology. It may represent the downstream consequence of neurodevelopmental difference interacting with chronic developmental stress, mediated in part through stress-sensitive opioid circuitry.

This does not imply that autism causes BPD. Rather, it proposes that the social environments in which autistic children develop may increase risk for trauma-mediated opioid dysregulation, which in turn contributes to BPD traits in a subset of individuals.

References